-- 
France Telecom, LVL Medical, Vetoquinol: Europe Equity Preview

-- B y   I n y o u n g   H w a n g
-- 
2011-06-08T04:00:02Z

-- http://www.bloomberg.com/news/2011-06-07/france-telecom-lvl-medical-vetoquinol-europe-equity-preview.html
Shares of the following companies may
have unusual moves in European trading. Stock symbols are in
parentheses.  The Stoxx  Europe  600 Index declined 0.1 percent to 271.87.
The Stoxx 50 Index fell 0.1 percent to 2,537.51. The Euro Stoxx
50 Index, a benchmark for nations using the euro, rose 0.3
percent to 2,774.5.  Eurogerm (ALGEM)  SA: The maker of food ingredients said
it formed a joint venture with Nisshin Seifun in  China . The
shares were unchanged at 14.61 euros.  France Telecom SA (FTE)  : Chief Executive Officer
Stephane Richard defended the company’s dividend after criticism
from trade unions. The 1.40 euro ($2.05) a share payout, which
represented about 45 percent of 2010 free  cash flow , “is on the
same basis as that of all the major listed telecom operators,”
he said. The shares gained 0.1 percent to 15.30 euros.  LVL Medical Groupe SA (LVL)  : Malakoff Mederic owns 10.29
percent of the home health-care company, Autorite des Marches
Financieres said. The shares climbed 1.9 percent to 17.94 euros.  Manitou Group (MTU FP): The industrial-vehicle maker said
Serge Bosche, vice president of sales and marketing for the
Americas region, resigned effective June 30. Daniel Miller,
president of the Compact division, will take over his duties
until a replacement can be found, the company said. The shares
fell 0.2 percent to 20.85 euros.  Meetic (MEET)  SA: FMR LLC cut its voting right stake in
the operator of Europe’s largest online dating network to 4.58
percent, Autorite des Marches Financieres said. The shares rose
0.1 percent to 14.97 euros.  Vetoquinol SA (VETO)  : The diagnostic tests maker said it
bought Farmagricola SA in  Brazil . The shares declined 0.2
percent to 30.15 euros.  To contact the reporter on this story:
Inyoung Hwang in New York at 
 ihwang7@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  